Stay updated on Nicotinamide Riboside in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Nicotinamide Riboside in Heart Failure Clinical Trial page.

Latest updates to the Nicotinamide Riboside in Heart Failure Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check12 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check55 days agoChange DetectedThe page has undergone a significant revision, changing from version v2.14.4 to v2.15.0, and has removed key collaborator information including the Principal Investigator's name and associated grant details.SummaryDifference0.9%
- Check63 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
Stay in the know with updates to Nicotinamide Riboside in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nicotinamide Riboside in Heart Failure Clinical Trial page.